• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
ZHAO Mengqi, LIAO Hong. Researches progress of the relationship between neuro-inflammation and cognitive function[J]. Journal of China Pharmaceutical University, 2019, 50(4): 497-504. DOI: 10.11665/j.issn.1000-5048.20190416
Citation: ZHAO Mengqi, LIAO Hong. Researches progress of the relationship between neuro-inflammation and cognitive function[J]. Journal of China Pharmaceutical University, 2019, 50(4): 497-504. DOI: 10.11665/j.issn.1000-5048.20190416
shu

Researches progress of the relationship between neuro-inflammation and cognitive function

More Information
    Graphical Abstract
    • Abstract
  • Dysfunctional learning and memorization ability as well as emotion exist in multiple central nervous diseases, which are disastrous to patients and their family. Reports indicate that neuro-inflammation is involved in various central nervous diseases; additionally, it participates in the regulation of learning and memorization ability as well as emotion. This article reviews data on several human diseases of animal model and clinical researches and discusses the relationship between neuro-inflammation and cognitive function. Some therapeutic researches targeting neuro-inflammation to improve neurological diseases are also summarized, with an attempt to provide inspiration and advice for the to development of drugs for diseases alike.
    • FullText(HTML)
    • References (49)
  • [1]
    Tripathi A,Paliwal P,Krishnamurthy S,et al.Piracetam attenuates LPS-induced neuroinflammation and cognitive impairment in rats[J].Cell Mol Neurobiol,2017,37(8):1373-1386.
    [2]
    Yin F,Sancheti H,Patil I,et al.Energy metabolism and inflammation in brain aging and Alzheimer′s disease[J].Free Radic Biol Med,2016,100:108-122.
    [3]
    Regen F,Hellmann-Regen J,Costantini E,et al.Neuroinflammation and Alzheimer′s disease:implications for microglial activation[J].Curr Alzheimer Res,2017,14(11):1140-1148.
    [4]
    Fang YQ,Yan J,Li CH,et al.The Nogo/Nogo receptor(NgR)signal is involved in neuroinflammation through the regulation of microglial inflammatory activation[J].J Biol Chem,2015,290(48):28901-28914.
    [5]
    Kohler O,Krogh J,Mors O,et al.Inflammation in depression and the potential for anti-inflammatory treatment[J].Curr Neuropharmacol,2016,14(7):732-742.
    [6]
    Young JJ, Bruno D, Pomara N. A review of the relationship between proinflammatory cytokines and major depressive disorder[J].J Affect Disord,2014,169:15-20.
    [7]
    Tuttolomondo A,Pecoraro R,Pinto A.Studies of selective TNF inhibitors in the treatment of brain injury from stroke and trauma:a review of the evidence to date[J].Drug Des Devel Ther,2014,7(8):2221-2238.
    [8]
    Burda JE,Bernstein AM,Sofroniew MV.Astrocyte roles in traumatic brain injury[J].Exp Neurol,2016,275(3):305-315.
    [9]
    Xu C,Fu F,Li XH,et al.Mesenchymal stem cells maintain the microenvironment of central nervous system by regulating the polarization of macrophages/microglia after traumatic brain injury[J].Int J Neurosci,2017,127(12):1124-1135.
    [10]
    Jassam YN,Izzy S,Whalen M,et al.Neuroimmunology of traumatic brain injury:time for a paradigm shift[J].Neuron,2017,95(6):1246-1265.
    [11]
    Pimplikar SW.Neuroinflammation in Alzheimer′s disease:from pathogenesis to a therapeutic target[J].J Clin Immunol,2014,34(Suppl 1):S64-69.
    [12]
    Balducci C,Frasca A,Zotti M,et al.Toll-like receptor 4-dependent glial cell activation mediates the impairment in memory establishment induced by β-amyloid oligomers in an acute mouse model of Alzheimer′s disease[J].Brain Behav Immun,2017,60:188-197.
    [13]
    Chen L, Hu LJ, Zhao JJ, et al. Chotosan improves Aβ1-42-induced cognitive impairment and neuroinflammatory and apoptotic responses through the inhibition of TLR-4/NF-κB signaling in mice[J].J Ethnopharmacol,2016,191:398-407.
    [14]
    Wang S,Zhang XW,Zhai LY,et al.Atorvastatin attenuates cognitive deficits and neuroinflammation induced by Aβ1-42 involving modulation of TLR4/TRAF6/NF-κB pathway[J].J Mol Neurosci,2018,64(3):363-373.
    [15]
    Qiang WJ,Cai WY,Yang Q,et al.Artemisinin B improves learning and memory impairment in AD dementia mice by suppressing neuroinflammation[J].Neuroscience,2018,395:1-12.
    [16]
    He PD, Yan SK, Zheng JJ, et al. Eriodictyol attenuates LPS-induced neuroinflammation,amyloidogenesis,and cognitive impairments via the inhibition of NF-κB in male C57BL/6J mice and BV2 microglial cells[J].J Agric Food Chem,2018,66(39):10205-10214.
    [17]
    Pandey GN,Rizavi HS,Ren XG,et al.Toll-like receptors in the depressed and suicide brain[J].J Psychiatr Res,2014,53:62-68.
    [18]
    Tan SJ,Wang Y,Chen K,et al.Ketamine alleviates depressive-like behaviors via down-regulating inflammatory cytokines induced by chronic restraint stress in mice[J].Biol Pharm Bull,2017,40(8):1260-1267.
    [19]
    Wang YH,Xu JJ,Liu Y,et al.TLR4-NF-κB signal involved in depressive-like behaviors and cytokine expression of frontal cortex and hippocampus in stressed C57BL/6 and ob/ob mice[J].Neural Plast,2018,72(54):7254016.
    [20]
    Gong H,Su WJ,Cao ZY,et al.Hippocampal mrp8/14 signaling plays a critical role in the manifestation of depressive-like behaviors in mice[J].J Neuroinflammation,2018,15(1):252.
    [21]
    Aboul-Fotouh S,Habib M,Asaad T,et al.Behavioral effects of toll-like receptor-4 antagonist ‘eritoran’ in an experimental model of depression:role of prefrontal and hippocampal neurogenesis and γ-aminobutyric acid/glutamate balance[J].Behav Pharmacol,2018,29(5):413-425.
    [22]
    Yao XL,Liu SW,Ding W,et al.TLR4 signal ablation attenuated neurological deficits by regulating microglial M1/M2 phenotype after traumatic brain injury in mice[J].J Neuroimmunol,2017,310:38-45.
    [23]
    Braun M,Vaibhav K,Saad N,et al.Activation of myeloid TLR4 mediates T lymphocyte polarization after traumatic brain injury[J].J Immunol,2017,198(9):3615-3626.
    [24]
    Li Y, Korgaonkar AA, Swietek B, et al. Toll-like receptor 4 enhancement of non-NMDA synaptic currents increases dentate excitability after brain injury[J].Neurobiol Dis,2015,74:240-253.
    [25]
    Jiang HS,Wang YZ,Liang X,et al.Toll-Like receptor 4 knockdown attenuates brain damage and neuroinflammation after traumatic brain injury via inhibiting neuronal autophagy and astrocyte activation[J].Cell Mol Neurobiol,2018,38(5):1009-1019.
    [26]
    Zhang DD,Li H,Li T,et al.TLR4 inhibitor resatorvid provides neuroprotection in experimental traumatic brain injury:implication in the treatment of human brain injury[J].Neurochem Int,2014,75:11-18.
    [27]
    Ye YQ, Xu HY, Zhang X, et al. Association between toll-like receptor 4 expression and neural stem cell proliferation in the hippocampus following traumatic brain injury in mice[J].Int J Mol Sci,2014,15(7):12651-12664.
    [28]
    Corrigan F,Arulsamy A,Collins-Praino LE,et al.Toll like receptor 4 activation can be either detrimental or beneficial following mild repetitive traumatic brain injury depending on timing of activation[J].Brain Behav Immun,2017,64:124-139.
    [29]
    Fujita K,Motoki K,Tagawa K,et al.HMGB1,a pathogenic molecule that induces neurite degeneration via TLR4-MARCKS,is a potential therapeutic target for Alzheimer′s disease[J].Sci Rep,2016,6:31895.
    [30]
    Festoff BW,Sajja RK,van Dreden P,et al.HMGB1 and thrombin mediate the blood-brain barrier dysfunction acting as biomarkers of neuroinflammation and progression to neurodegeneration in Alzheimer′s disease[J].J Neuroinflammation,2016,13(1):194.
    [31]
    Foo H,Ng KP,Tan J,et al.Interaction between APOE-ε4 and HMGB1 is associated with widespread cortical thinning in mild cognitive impairment[J].J Neurol Neurosurg Psychiatry,2018,89(2):225-226.
    [32]
    Wang B, Lian YJ, Su WJ, et al. HMGB1 mediates depressive behavior induced by chronic stress through activating the kynurenine pathway[J].Brain Behav Immun,2018,72:51-60.
    [33]
    Lian YJ, Gong H, Wu TY, et al. Ds-HMGB1 and fr-HMGB induce depressive behavior through neuroinflammation in contrast to nonoxid-HMGB1[J].Brain Behav Immun,2017,59:322-332.
    [34]
    Wu TY, Liu L, Zhang W, et al. High-mobility group box-1 was released actively and involved in LPS induced depressive-like behavior[J].J Psychiatr Res,2015,64:99-106.
    [35]
    Okuma Y,Liu KY,Wake H,et al.Glycyrrhizin inhibits traumatic brain injury by reducing HMGB1-RAGE interaction[J].Neuropharmacology,2014,85:18-26.
    [36]
    Okuma Y,Liu KY,Wake H,et al.Anti-high mobility group box-1 antibody therapy for traumatic brain injury[J].Ann Neurol,2012,72(3):373-384.
    [37]
    Paudel YN,Shaikh MF,Chakraborti A,et al.HMGB1:a common biomarker and potential target for TBI,neuroinflammation,epilepsy,and cognitive dysfunction[J].Front Neurosc,2018,12:628.
    [38]
    Nakaizumi K,Ouchi Y,Terada T,et al.In vivo depiction of α7 nicotinic receptor loss for cognitive decline in Alzheimer′s disease[J].J Alzheimers Dis,2018,61(4):1355-1365.
    [39]
    Pirttimaki TM,Codadu NK,Awni A,et al.α7 Nicotinic receptor-mediated astrocytic gliotransmitter release:Aβ effects in a preclinical Alzheimer′s mouse model[J].PLoS One,2013,8(11):e81828.
    [40]
    Inestrosa NC,Godoy JA,Vargas JY,et al.Nicotine prevents synaptic impairment induced by amyloid-β oligomers through α7-nicotinic acetylcholine receptor activation[J].Neuromolecular Med,2013,15(3):549-569.
    [41]
    Wang CH,Chen TT,Li GX,et al.Simvastatin prevents β-amyloid(25-35)-impaired neurogenesis in hippocampal dentate gyrus through α7nAChR-dependent cascading PI3K-Akt and increasing BDNF via reduction of farnesyl pyrophosphate[J].Neuropharmacology,2015,97:122-132.
    [42]
    Niemegeers P,de Boer P,Schuermans J,et al.Digging deeper in the differential effects of inflammatory and psychosocial stressors in remitted depression:effects on cognitive functioning[J].J Affect Disord,2019,245:356-363.
    [43]
    Zhao D,Xu X,Pan L,et al.Pharmacologic activation of cholinergic alpha7 nicotinic receptors mitigates depressive-like behavior in a mouse model of chronic stress[J].J Neuroinflammation,2017,14(1):234.
    [44]
    Schmöle AC,Lundt R,Ternes S,et al.Cannabinoid receptor 2 deficiency results in reduced neuroinflammation in an Alzheimer′s disease mouse model[J].Neurobiol Aging,2015,36(2):710-719.
    [45]
    Stumm C,Hiebel C,Hanstein R,et al.Cannabinoid receptor 1 deficiency in a mouse model of Alzheimer′s disease leads to enhanced cognitive impairment despite of a reduction in amyloid deposition[J].Neurobiol Aging,2013,34(11):2574-2584.
    [46]
    Jayant S,Sharma BM,Bansal R,et al.Pharmacological benefits of selective modulation of cannabinoid receptor type 2(CB2)in experimental Alzheimer′s disease[J].Pharmacol Biochem Behav,2016,140:39-50.
    [47]
    Wu J,Hocevar M,Foss JF,et al.Activation of CB2 receptor system restores cognitive capacity and hippocampal Sox2 expression in a transgenic mouse model of Alzheimer′s disease[J].Eur J Pharmacol,2017,811:12-20.
    [48]
    Haj-Mirzaian A,Amini-Khoei H,Haj-Mirzaian A,et al.Activation of cannabinoid receptors elicits antidepressant-like effects in a mouse model of social isolation stress[J].Brain Res Bull,2017,130:200-210.
    [49]
    Kruk-Slomka M,Michalak A,Biala G,et al.Antidepressant-like effects of the cannabinoid receptor ligands in the forced swimming test in mice:mechanism of action and possible interactions with cholinergic system[J].Behav Brain Res,2015,284:24-36.
    • Related Articles

  • Related Articles

    [1]PEI Xin, LI Guideng, CHU Weihua. Progress of proximity labeling technology in membrane protein interaction[J]. Journal of China Pharmaceutical University, 2024, 55(2): 158-166. DOI: 10.11665/j.issn.1000-5048.2023041303
    [2]YANG Wanwan, YE Fangyu, WU Yujia, WANG Haochen, ZHAO Li. Research progress of PARP inhibitors in cancers and their drug resistance[J]. Journal of China Pharmaceutical University, 2022, 53(5): 525-534. DOI: 10.11665/j.issn.1000-5048.20220503
    [3]WANG Zhenghao, GAO Yafeng, ZHANG Lianjun, LIU Chang. Research progress of T cell anti-tumor function regulated by endoplasmic reticulum stress[J]. Journal of China Pharmaceutical University, 2022, 53(5): 518-524. DOI: 10.11665/j.issn.1000-5048.20220502
    [4]BU Hong, ZHOU Jinpei, ZHANG Huibin. Research progress of mitogen-activated protein kinase interacting kinases inhibitors in tumor immunotherapy[J]. Journal of China Pharmaceutical University, 2021, 52(4): 410-421. DOI: 10.11665/j.issn.1000-5048.20210403
    [5]WANG Tianshuai, YU Junjie, ZHANG Yan, ZENG Jinjin, CUI Jingxin. Advances in platinum-intercalators of DNA as antitumor agents[J]. Journal of China Pharmaceutical University, 2019, 50(5): 505-515. DOI: 10.11665/j.issn.1000-5048.20190501
    [6]GUO Yahui, LU Peng, WANG Yubin, ZHANG Huibin. Progress in the researches for antitumor NEDD8 activating enzyme inhibitors[J]. Journal of China Pharmaceutical University, 2017, 48(6): 646-653. DOI: 10.11665/j.issn.1000-5048.20170603
    [7]ZHANG Danfeng, JIAO Yu, LIU Yong, ZHANG Yanmin, ZHANG Zhimin, LU Tao. Progress of small molecule anti-tumor covalent drugs[J]. Journal of China Pharmaceutical University, 2017, 48(1): 1-7. DOI: 10.11665/j.issn.1000-5048.20170101
    [8]YAO Aihong, CHANG Yujie, JIANG Cheng, SUN Haiying. Research progress of Polo-like kinase 1 inhibitors targeting Polo-box domain[J]. Journal of China Pharmaceutical University, 2016, 47(1): 1-8. DOI: 10.11665/j.issn.1000-5048.20160101
    [9]ZHANG Jinghui, WANG Yajing, HU Rong. Roles of Moesin in tumor progression[J]. Journal of China Pharmaceutical University, 2015, 46(3): 371-375. DOI: 10.11665/j.issn.1000-5048.20150319
    [10]LI Linhu, CHEN Li, XIA Yufeng. Progress in the study of coumarin derivatives as antitumor agents[J]. Journal of China Pharmaceutical University, 2013, 44(4): 374-379. DOI: 10.11665/j.issn.1000-5048.20130417

Catalog

    Get Citation
    PDF
    XML
    Article views (885) PDF downloads (1446) Cited by()
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    Copyright © Journal of China Pharmaceutical University苏ICP备12050101号-2

    Address：24 Tongjia Lane, Nanjing City, Jiangsu Province （210009）Tel: 025-83271566E-mail: xuebao@cpu.edu.cn

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    Total visits：297250

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return